Alecensa 150 MG capsule UU 240S
Ended Awarded Last action
- Contract number
- SPE2DR26FHNU0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,253
Award facts
- Contract value 100% obligated
- $19,252.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,252.64 to DMS Pharmaceutical Group Inc. on January 5, 2026, for the supply of Alecensa 150 mg capsules (240 units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under firm fixed-price terms with no set-aside designation. The delivery order is scheduled for completion by January 27, 2026, and will be performed at the contractor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to supply pharmaceutical products to Department of Defense military healthcare facilities globally. The contract, awarded on November 13, 2025, with a $499.9 million ceiling value and completion date of December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, biologics, and medical consumables. DMS Pharmaceutical Group's selection reflects its established capability to supply specialized pharmaceutical requirements across diverse therapeutic categories in support of military medical operations.
Quick answers
Who was awarded contract SPE2DR26FHNU0?
SPE2DR26FHNU0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FHNU0 worth?
The government has obligated $19,253 on SPE2DR26FHNU0.
Is contract SPE2DR26FHNU0 an order under another contract?
Yes. SPE2DR26FHNU0 is a delivery order under SPE2DR25D9231, an indefinite delivery contract.
Was contract SPE2DR26FHNU0 competed?
The extent of competition for SPE2DR26FHNU0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award